Karan S Dixit

17PUBLICATIONS
116CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursImmunogenetics (incl. genetic immunology)Pacific Peoples social determinants of healthSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 26, 2026
Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205.

|May 11, 2026
Efficacy of tepotinib in patients with high-grade glioma with <i>MET</i> alterations: A case series.

|Mar 17, 2026
Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study.

Leon D Kaulen, Lakshmi Nayak, Philipp Karschnia

|Feb 10, 2026
Assessments of social vulnerability on central nervous system cancer disparities in the United States.

David J Fei-Zhang, Salim C Lutfallah, Joshua Mensah

|Jan 28, 2026
A phase 2, open label, clinical trial of pre-surgical and adjuvant treatment of recurrent glioblastoma with tremelimumab and durvalumab alone and in combination.

Karan S Dixit, Priya Kumthekar, Rimas V Lukas

|Nov 13, 2025
Surgical Treatment of Brain Tumor-Related Epilepsy: Current and Emerging Strategies.

Bobak F Khalili, Michael R Chojnacki, Karan Dixit

Pageof 3

Frequent Collaborators

5 joint publications

Rimas V Lukas

5 joint publications

Priya U Kumthekar

3 joint publications

Bobak F Khalili

3 joint publications

Craig Horbinski